Global Eszopiclone Market 2023-2030

    In Stock

    Coming Soon




    Insomnia can be treated with ezopiclone. (difficulty falling asleep or staying asleep). Eszopiclone belongs to the group of drugs known as hypnotics. It functions by reducing brain activity to promote sleep. Eszopiclone is available as a tablet to be swallowed.


    It is often used once daily, either before bed or after attempting unsuccessfully to fall asleep.Avoid using eszopiclone right before or right after a filling, high-fat meal.If you take ezopiclone with high-fat foods, it could not work as well.


    Eszopiclone use may be followed by complex sleep behaviours such as sleepwalking, sleep driving, and engaging in other activities while not fully awake. Serious injuries, even death, could be caused by some of these occurrences.


    Any patient who exhibits complex sleep behaviour while taking eszopiclone should have their medication stopped right away by their doctor.


    Eszopiclone is offered under the trade name Lunesta. It is moreover a generic medication. Drugs that are generic typically cost less than those that are brand-name. The brand-name medication and its generic equivalent could occasionally come in various dosages and strengths.


    Eszopiclone is an illegal drug. This implies that there is a chance of drug abuse and that dependence could result. Eszopiclone is a member of the sedative-hypnotic drug subclass.


    A class of pharmaceuticals is a collection of compounds with comparable mechanisms of action. Similar problems are frequently treated with these medications.




    infographic: Eszopiclone Market, Eszopiclone Market Size, Eszopiclone Market Trends, Eszopiclone Market Forecast, Eszopiclone Market Risks, Eszopiclone Market Report, Eszopiclone Market Share


    The Global Eszopiclone Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    Eszopiclone is a drug used to treat insomnia and is marketed under the trade names Lunesta and others.Evidence points to a minimal to moderate benefit for the first six months. It’s consumed orally.


    Headache, dry mouth, nausea, and dizziness are typical adverse effects. Suicidal thoughts, unhealthy non-medical use, hallucinations, and angioedema are examples of severe adverse effects. Elderly adults and those with liver issues should be treated with more caution. Withdrawal may occur if the dose is reduced quickly. 


    Eszopiclone belongs to the cyclopyrrolone family of sedatives and hypnotics and is categorised as a nonbenzodiazepine or Z-drug.It is zopiclone’s S-stereoisomer. It functions by engaging the GABA receptors.


    Eszopiclone is a drug used to treat insomnia and is marketed under the trade names Lunesta and others. Evidence points to a minimal to moderate benefit for the first six months. It’s consumed orally.


    Despite the benefits of medication being usually underwhelming, older patients are more frequently prescribed sedative hypnotic medications, such as eszopiclone. To reduce side effects, it is important to take care while selecting an appropriate hypnotic medicine and to start pharmacological therapy at the lowest dose possible.



    • Zolnite
    • Zopim
    • Sunovion Pharmaceuticals Inc.


    1. How many Eszopicloneare manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global EszopicloneAnd key vendor selection criteria
    3. Where are EszopicloneManufactured? What is the average margin per unit?
    4. Market share of Global EszopicloneMarket manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global EszopicloneIn-house
    6. key predictions for next 5 years in Global EszopicloneMarket
    7. Average B-2-B EszopicloneMarket price in all segments
    8. Latest trends in EszopicloneMarket, by every market segment
    9. The market size (both volume and value) of the EszopicloneMarket in 2023-2030 and every year in between?
    10. Production breakup of EszopicloneMarket, by suppliers and their OEM relationship



    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop